| 000 | 01220 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250515210110.0 | ||
| 264 | 0 | _c20100805 | |
| 008 | 201008s 0 0 eng d | ||
| 022 | _a1873-4316 | ||
| 024 | 7 |
_a10.2174/138920110790909641 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSajjad, M U | |
| 245 | 0 | 0 |
_aHeat shock proteins: therapeutic drug targets for chronic neurodegeneration? _h[electronic resource] |
| 260 |
_bCurrent pharmaceutical biotechnology _cFeb 2010 |
||
| 300 |
_a198-215 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBrain _xdrug effects |
| 650 | 0 | 4 | _aChronic Disease |
| 650 | 0 | 4 |
_aHeat-Shock Proteins _xbiosynthesis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMolecular Structure |
| 650 | 0 | 4 |
_aNeurodegenerative Diseases _xdrug therapy |
| 650 | 0 | 4 |
_aNeuroprotective Agents _xadverse effects |
| 650 | 0 | 4 |
_aPrions _xmetabolism |
| 650 | 0 | 4 | _aProtein Folding |
| 700 | 1 | _aSamson, B | |
| 700 | 1 | _aWyttenbach, A | |
| 773 | 0 |
_tCurrent pharmaceutical biotechnology _gvol. 11 _gno. 2 _gp. 198-215 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2174/138920110790909641 _zAvailable from publisher's website |
| 999 |
_c19536429 _d19536429 |
||